For the first time, we observed that overexpression of MD-1 in mouse hearts attenuated chronic pressure overload-induced cardiac remodelling, whereas loss of MD-1 promoted the development of pathological cardiac hypertrophy. Here, LY86 is linked to cardiac hypertrophy.